Part of the work presented here was made possible thru a personal grant from the Ränk Family and administered by the Swedish Heart and Lung Foundation. Thank you - Marianne, Ristjan, Martina and Stefan - for your generous financial support and for your genuine and inspiring interest in my work over the years.
If you want to contact me, please use the form below.
My name is Anna-Karin Hamberg and I am a pharmacist by training. I received both my MSc in Pharmacy and my PhD in Medical Sciences from Uppsala University, Sweden. I have over 20 years experience as a regulatory expert in pharmacokinetics and paediatric clinical pharmacology, mainly working for the Swedish Medical Products Agency (MPA) in Uppsala, but also for the European Medicines Agency (EMA) in London, WHO in Geneva and NDA Regulatory Service in Upplands Väsby. My primary research interest has been development and implementation of better tools for therapeutic drug monitoring and dose individualisation through the integration of modelling and simulation into clinical decision support systems. In September 2014 I returned to the MPA, to the unit of Scientific Expertise, and from December 2014 I am appointed Swedish alternate in the Paediatric Committee (PDCO) at EMA.
The opinions stated on this website represents my personal view if not stated otherwise, and do not represent any official view of the MPA.